reduc serum 25hydroxyvitamin concentr disord miner metabol patient cystic fibrosi vitamin miner metabol studi 21 adolesc young adult cystic fibrosi result compar 21 match control cf patient maintain standard multivitamin supplement combin pancreat enzym replac despit thi supplement rel control subject cf patient 36 reduct serum 25 hydroxyvitamin concentr slight signific reduct serum calcium concentr evid calcium malabsorpt secondari hyperparathyroid 14 decreas bone mass measur photon absorpt techniqu current accept mode pancreat enzym replac vitamin supplement often inadequ maintain normal miner homeostasi cf patient addit measur may requir reduc risk clinic signific osteopenia concomit prolong surviv cf